Endometrial cancer, also known as uterine cancer, primarily originates in the lining of the uterus, called the endometrium. It is the most common form of cancer affecting the female reproductive system and often occurs after menopause, although it can also affect younger women. The cancer is typically diagnosed at an early stage due to the common symptom of abnormal vaginal bleeding, leading to a favorable prognosis when detected early. Treatment options usually include surgery, radiation therapy, and hormone therapy, depending on the stage and overall health of the patient.

Several factors increase the risk of developing endometrial cancer, including obesity, which raises estrogen levels, and hormonal imbalances related to conditions like polycystic ovary syndrome (PCOS). Other risk factors include age (with most cases occurring in women over 50), family history of endometrial or other related cancers, and certain genetic conditions such as Lynch syndrome. Additionally, prolonged use of estrogen without progesterone and diabetes have been associated with an elevated risk.

The most common symptom of endometrial cancer is abnormal vaginal bleeding, which may manifest as irregular periods, bleeding between periods, or bleeding after menopause. Other symptoms can include pelvic pain, unexplained weight loss, and changes in bowel or bladder habits. Some women may also experience pain during sexual intercourse. It is essential for women experiencing these symptoms to consult a healthcare professional for evaluation.

Endometrial cancer, a type of cancer affecting the lining of the uterus, is primarily influenced by hormonal factors. Increased exposure to estrogen, whether from obesity, hormone replacement therapy, or early menstruation and late menopause, can elevate the risk. Additionally, genetic factors, including mutations linked to Lynch syndrome, and certain medical conditions such as polycystic ovary syndrome (PCOS) also contribute to the development of this cancer.

Diagnosis of endometrial cancer typically involves a combination of patient history, physical examinations, and diagnostic tests. Healthcare providers may perform a pelvic exam, transvaginal ultrasound, or endometrial biopsy, where a sample of the uterine lining is taken for analysis. Imaging studies such as CT scans or MRIs may also be utilized to determine the extent of cancer spread. Once diagnosed, staging of the cancer is crucial for determining the appropriate treatment approach.

Treatment for endometrial cancer typically involves a multi-disciplinary approach and depends on the stage and grade of the cancer. Common interventions include surgical procedures such as hysterectomy, possibly accompanied by lymph node dissection, followed by adjuvant therapies like radiation or chemotherapy to eliminate remaining cancer cells. Hormonal therapy may also be considered, particularly in cases of low-grade tumors or in patients who are candidates for fertility preservation.

While there is no guaranteed way to prevent endometrial cancer, certain lifestyle choices can significantly reduce risk. Maintaining a healthy weight, engaging in regular physical activity, and following a balanced diet rich in fruits, vegetables, and whole grains can help lower risk. Additionally, managing hormonal imbalances and discussing preventive measures with healthcare providers, especially for those with a family history of cancer, can aid in early detection and prevention strategies.